MNX Market Network Exchange
Commercial intelligence · New York
Menu
$1,000The New York strategy we build for retained clients, made accessible.Build my strategy →

Live · Open opportunity

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

National Institutes of Health

ShareLinkedIn ↗Email
Issuer
National Institutes of Health
Type
Federal funding opportunity
Jurisdiction
federal
Posted
August 31, 2026
Closes
June 16, 2028

Detail

This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use. For projects not requiring a phased research approach, applicants are encouraged to apply under a different funding activity code (e.g., PA-25-305 "Research Project Grant (Parent R01 Clinical Trial Required)" or its subsequent reissue).

mental-health-substance-usefederalgrants.gov

View the full solicitation and how to apply ↗

Free account

Create a free account

Track New York opportunities and save searches across the Market. Free. No card required.

Want a strategy to win work like this? Build your Market Network Strategic Plan →